Introduction:
The Price to Book Value (P/B ratio) is a key financial metric that evaluates a company’s market value relative to its book value. It reveals the price investors are willing to pay for each unit of net assets owned by the company.
A lower P/B ratio may indicate that a company is undervalued, presenting a potential investment opportunity. Conversely, a higher ratio might suggest overvaluation, implying that the market price exceeds the company’s underlying asset value.
Avance Technologies Ltd
On November 21, 2024, Avance Technologies Ltd stock opened at ₹0.96, reflecting a 1.05% increase from the previous close of ₹0.95. The stock reached an intraday high of ₹0.98 and a low of ₹0.91. By market close, it remained unchanged at ₹0.95, with a market capitalization of ₹188.28 crore.
Avance Technologies Ltd has a stock P/E ratio of 21.08, reflecting a reasonable market valuation. The company reports a 1.35% ROCE, indicating moderate operational efficiency. With a price-to-book ratio of 0.49, Avance Technologies appears to be undervalued in the market.
Avance Technologies Ltd (NSE: AVANCE), established in 1985, specializes in IT products and software solutions. The company offers a broad range of services, including digital marketing, SEO, mobile app marketing, cloud services, AI, blockchain, and software testing, aiming to drive growth and innovation for clients.
Cian Healthcare Ltd
On November 21, 2024, Cian Healthcare Ltd stock opened at ₹4.81, reflecting a 1.84% decrease from the previous close of ₹4.90. The stock reached an intraday high and low of ₹4.81. By 4:00 PM, the stock closed at ₹4.81, down 1.84%. The company’s market capitalization stands at ₹12.02 crore.
Cian Healthcare Ltd has a stock P/E ratio of 48.1, indicating moderate valuation. The company shows a 5.22% ROCE, reflecting reasonable operational efficiency. With a price-to-book ratio of 0.21, Cian Healthcare appears to be undervalued in the market.
Cian Healthcare Ltd (NSE: CIAN) was established in 2003 and specializes in manufacturing and marketing pharmaceutical products across various sectors, including gynecology, cardio-diabetic, pediatric, and veterinary products. The company operates through own brands, third-party manufacturing, and institutional supply.
Also Read: Navratna stock in focus after it receives order worth ₹202 Cr for PMEkta Mall at Jaipur
Filatex Fashions Ltd
On November 21, 2024, Filatex Fashions Ltd opened at ₹0.92, reflecting a 1.08% decrease from the previous close of ₹0.93. The stock reached an intraday high and low of ₹0.92. By 4:00 PM, the stock closed at ₹0.92, down 1.08%. The company’s market capitalization stands at ₹766.73 crore.
Filatex Fashions Ltd has a stock P/E ratio of 83.1, indicating a high market valuation. Its ROCE is 1.07%, suggesting limited returns on capital, while a price-to-book ratio of 0.33 suggests it is undervalued compared to its assets.
Filatex Fashions Ltd (NSE: FILATFASH), established in 1995, specializes in manufacturing high-quality socks using advanced infrared technology. Known for its zero-rejection quality standards, Filatex serves global brands like FILA, Adidas, and Disney. The company’s skilled workforce has received training in Italy and China to ensure consistent production.
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.
